has subject area Antibodies, Monoclonal, Humanized Bisphosphonate-Associated Osteonecrosis of the Jaw Bone Density Conservation Agents Clinical Protocols Denosumab Diphosphonates Humans Osteoclasts Risk Factors Teriparatide